AllerGen NCE Inc. is governed by an independent Board of Directors (BoD) committed to the vision and mission of the Network. Board Directors promote an atmosphere where research excellence and industry expertise unite to provide socio-economic benefits for Canadians. The BoD is responsible for the overall governance of the Network and acts in accordance with the By-Laws of AllerGen NCE Inc.
AllerGen’s BoD ensures that Network management pursues appropriate corporate directions and develops, maintains and implements investments, processes and strategic plans in accordance with Network policies and priorities.
Current Board Members
Daniel Nixon, MBA (Chair)
President, Oak Capital Corporation
Mr. Nixon is a seasoned executive with extensive private equity, investment banking and operations experience.
Paul O’Byrne, MB, FRCPI, FRCPC, FRCPE, FRCP(Glasg), FAPC, FCCP, FERS, FRSC
Professor, Division of Respirology, Department of Medicine, and Dean and Vice-President, Faculty of Health Sciences, McMaster University, St. Joseph’s Healthcare
Dr. O’Byrne is world renowned for his research on asthma that is the result of allergies.
President and CEO, AllerGen NCE Inc.
Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.
Padmaja Subbarao, MD, FRCPC, Msc. (Epid)
Director, Pulmonary Function Laboratory, and Clinician-Scientist, Respirologist, Hospital for Sick Children; Associate Professor, Department of Paediatrics, University of Toronto; Director, CHILD Cohort Study
Dr. Subbarao’s primary research interest is in the early determinants and development of asthma. Specifically, she is studying changes in infant lung function biomarkers of inflammation in this understudied group to elucidate the effect of environment and viruses on the early development of disease.
Former Executive Director, Canadian Thoracic Society
Ms Sutherland was executive Director of CTS from 2015-2022, leading the organizarion and designing its overall stratgy. CTS is recognized as the national specialty society for respirology in Canada with members representing specialists, physicians, researchers and healthcare professionals from a variety of disciplines working in respiratory health.